The Role of PIWI-Interacting RNA in Urologic Carcinoma and Its Clinical Implications

IF 1.9 Q4 ONCOLOGY
Cancer reports Pub Date : 2025-07-30 DOI:10.1002/cnr2.70272
Jiajia Cai, Shirui Jiang, Dongdong Lu, Ghulam Murtaza, Mingbang Wang, Yuqing Li, Da Shi, Yingrui Li, Hu Fang, Song Wu
{"title":"The Role of PIWI-Interacting RNA in Urologic Carcinoma and Its Clinical Implications","authors":"Jiajia Cai,&nbsp;Shirui Jiang,&nbsp;Dongdong Lu,&nbsp;Ghulam Murtaza,&nbsp;Mingbang Wang,&nbsp;Yuqing Li,&nbsp;Da Shi,&nbsp;Yingrui Li,&nbsp;Hu Fang,&nbsp;Song Wu","doi":"10.1002/cnr2.70272","DOIUrl":null,"url":null,"abstract":"<p>Piwi-interacting RNA (piRNA) represents a class of small non-coding RNA molecules, typically ranging in length from 18 to 35 nucleotides. These molecules are critically involved in the preservation of genomic integrity and the regulation of protein translation processes. Recently, emerging scholarly research indicates that piRNA exhibits tissue-specific expression profiles within a variety of human malignancies, where they intricately regulate key signaling pathways at both the transcriptional and post-transcriptional levels. This review systematically underscores current investigations pertaining to piRNA in urologic carcinoma (UC), elucidating the proposed regulatory mechanisms encompassing N6-methyladenosine (m6A) modification and the silencing of transposable elements. Furthermore, we discuss the detection technology and the application of piRNA in the fields of clinical diagnosis.</p>","PeriodicalId":9440,"journal":{"name":"Cancer reports","volume":"8 8","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cnr2.70272","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70272","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Piwi-interacting RNA (piRNA) represents a class of small non-coding RNA molecules, typically ranging in length from 18 to 35 nucleotides. These molecules are critically involved in the preservation of genomic integrity and the regulation of protein translation processes. Recently, emerging scholarly research indicates that piRNA exhibits tissue-specific expression profiles within a variety of human malignancies, where they intricately regulate key signaling pathways at both the transcriptional and post-transcriptional levels. This review systematically underscores current investigations pertaining to piRNA in urologic carcinoma (UC), elucidating the proposed regulatory mechanisms encompassing N6-methyladenosine (m6A) modification and the silencing of transposable elements. Furthermore, we discuss the detection technology and the application of piRNA in the fields of clinical diagnosis.

Abstract Image

piwi相互作用RNA在泌尿系统癌中的作用及其临床意义
piwi相互作用RNA (piRNA)是一类小的非编码RNA分子,通常长度在18到35个核苷酸之间。这些分子在保存基因组完整性和调节蛋白质翻译过程中起着至关重要的作用。最近,新兴的学术研究表明,piRNA在多种人类恶性肿瘤中表现出组织特异性表达谱,在转录和转录后水平上复杂地调节关键信号通路。本综述系统地强调了目前有关泌尿系统癌(UC)中piRNA的研究,阐明了包括n6 -甲基腺苷(m6A)修饰和转座因子沉默在内的拟议调节机制。并对piRNA的检测技术及其在临床诊断中的应用进行了讨论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer reports
Cancer reports Medicine-Oncology
CiteScore
2.70
自引率
5.90%
发文量
160
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信